Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 376

1.

Intralesional and subcutaneous application of Viscum album L. (European mistletoe) extract in cervical carcinoma in situ: A CARE compliant case report.

Reynel M, Villegas Y, Kiene H, Werthmann PG, Kienle GS.

Medicine (Baltimore). 2018 Nov;97(48):e13420. doi: 10.1097/MD.0000000000013420.

2.

The Internal Coherence of Breast Cancer Patients Is Associated with the Decision-Making for Chemotherapy and Viscum album L. Treatment.

Oei SL, Thronicke A, Kröz M, Herbstreit C, Schad F.

Evid Based Complement Alternat Med. 2018 Sep 27;2018:1065271. doi: 10.1155/2018/1065271. eCollection 2018.

3.

Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.

Pelzer F, Tröger W, Nat DR.

J Altern Complement Med. 2018 Sep/Oct;24(9-10):954-961. doi: 10.1089/acm.2018.0159.

4.

Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice.

Schötterl S, Huber SM, Lentzen H, Mittelbronn M, Naumann U.

Evid Based Complement Alternat Med. 2018 Aug 27;2018:3928572. doi: 10.1155/2018/3928572. eCollection 2018.

5.

Safety of high-dose intravenous mistletoe therapy in pediatric cancer patients: A case series.

Zuzak TJ, Wasmuth A, Bernitzki S, Schwermer M, Längler A.

Complement Ther Med. 2018 Oct;40:198-202. doi: 10.1016/j.ctim.2018.01.002. Epub 2018 Jan 11.

PMID:
30219449
6.

Efficacy and safety of Viscum album extract (Helixor-M) to treat malignant pleural effusion in patients with lung cancer.

Lee YG, Jung I, Koo DH, Kang DY, Oh TY, Oh S, Lee SS.

Support Care Cancer. 2018 Sep 14. doi: 10.1007/s00520-018-4455-z. [Epub ahead of print]

PMID:
30218188
7.

Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients.

Thronicke A, Oei SL, Merkle A, Matthes H, Schad F.

Medicines (Basel). 2018 Sep 6;5(3). pii: E100. doi: 10.3390/medicines5030100.

8.

Complete Remission and Long-term Survival of a Patient with a Diffuse Large B-cell Lymphoma Under Viscum album Extracts After Resistance to R-CHOP: A Case Report.

Gutsch J, Werthmann PG, Rosenwald A, Kienle GS.

Anticancer Res. 2018 Sep;38(9):5363-5369. doi: 10.21873/anticanres.12865.

PMID:
30194190
9.

Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis.

Schad F, Thronicke A, Steele ML, Merkle A, Matthes B, Grah C, Matthes H.

PLoS One. 2018 Aug 27;13(8):e0203058. doi: 10.1371/journal.pone.0203058. eCollection 2018.

10.

[Ribosome Inactivation and the Integrity of the Intestinal Epithelial Barrier].

Nikulin SV, Mnafki Krainova NA, Shilin SA, Gazizov IN, Maltseva DV.

Mol Biol (Mosk). 2018 Jul-Aug;52(4):675-682. doi: 10.1134/S0026898418040146. Russian.

11.

Durable clinical remission of a skull metastasis under intralesional Viscum album extract therapy: Case report.

Werthmann PG, Huber R, Kienle GS.

Head Neck. 2018 Jul;40(7):E77-E81. doi: 10.1002/hed.25320. Epub 2018 Jun 9.

12.

A 21-year course of Merkel cell carcinoma with adjuvant Viscum album extract treatment: A case report.

Werthmann PG, Kindermann L, Kienle GS.

Complement Ther Med. 2018 Jun;38:58-60. doi: 10.1016/j.ctim.2018.04.001. Epub 2018 Apr 9.

13.

Crystal Structure of Mistletoe Lectin I (ML-I) from Viscum album in Complex with 4-N-Furfurylcytosine at 2.85 Å Resolution.

Ahmad MS, Rasheed S, Falke S, Khaliq B, Perbandt M, Choudhary MI, Markiewicz WT, Barciszewski J, Betzel C.

Med Chem. 2018;14(8):754-763. doi: 10.2174/1573406414666180524095946.

PMID:
29792147
14.

The Stability of Medicinal Plant microRNAs in the Herb Preparation Process.

Xie W, Melzig MF.

Molecules. 2018 Apr 16;23(4). pii: E919. doi: 10.3390/molecules23040919.

15.

Phenolic compounds from Viscum album tinctures enhanced antitumor activity in melanoma murine cancer cells.

Melo MNO, Oliveira AP, Wiecikowski AF, Carvalho RS, Castro JL, de Oliveira FAG, Pereira HMG, da Veiga VF, Capella MMA, Rocha L, Holandino C.

Saudi Pharm J. 2018 Mar;26(3):311-322. doi: 10.1016/j.jsps.2018.01.011. Epub 2018 Jan 31.

16.

Implementation of an Integrative Oncological Concept in the Daily Care of a German Certified Breast Cancer Center.

Schad F, Thronicke A, Merkle A, Steele ML, Kröz M, Herbstreit C, Matthes H.

Complement Med Res. 2018;25(2):85-91. doi: 10.1159/000478655. Epub 2018 Mar 7.

17.

Safety of Combined Treatment With Monoclonal Antibodies and Viscum album L Preparations.

Schad F, Axtner J, Kröz M, Matthes H, Steele ML.

Integr Cancer Ther. 2018 Mar;17(1):41-51. doi: 10.1177/1534735416681641. Epub 2016 Dec 1.

18.
19.

[Kombinierte Anwendung von Strahlentherapie und adjuvanter Therapie mit einem Mistelextrakt (Viscum album L.) zur Behandlung des oralen malignen Melanoms beim Hund: Eine retrospektive Studie].

von Bodungen U, Ruess K, Reif M, Biegel U.

Complement Med Res. 2017;24(6):358-363. doi: 10.1159/000485743. Epub 2017 Dec 15. German.

20.

Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer.

Thronicke A, Steele ML, Grah C, Matthes B, Schad F.

BMC Complement Altern Med. 2017 Dec 13;17(1):534. doi: 10.1186/s12906-017-2045-0.

Supplemental Content

Loading ...
Support Center